FT-003
FT003WA-1
Phase 1 gene_therapy active
Quick answer
FT-003 for Neovascular Age-related Macular Degeneration is a Phase 1 program (gene_therapy) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Neovascular Age-related Macular Degeneration
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- active